A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 301 participants.

Also called NCT06450366

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 301 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06450366
  • EU CT 2023-504920-25-00
  • WHO UTN U1111-1290-3888
Other papers using this trial's data
  • Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies: A Phase 3 Randomized Clinical Trial Journal of the American College of Cardiology, 2026-07-21 DOI, PubMed 42017875

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Canada, France, Israel, Spain, Taiwan, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06450366. Randomized; triple masking; primary purpose treatment. Start 2024-07-08 (actual); primary completion 2025-02-14 (actual). Results posted on 2026-03-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)
Condition
Hypercholesterolemia
Intervention (Drug)
Enlicitide
Intervention (Drug)
Ezetimibe
Intervention (Drug)
Bempedoic Acid
Intervention (Other)
Placebo for Enlicitide
Intervention (Other)
Placebo for Ezetimibe
Intervention (Other)
Placebo for Bempedoic Acid
Lead sponsor
Merck Sharp & Dohme LLC (class: industry)

Record details

Record id
cardio:ct-nct06450366
Content hash
d6fc619948e0036942accdcb524a0b7cceb8a59531ae462c7f26c1591e7b7f26